Plasmin, not only functions as a key enzyme in the fibrinolytic system but also directly inactivates factor VIII and other clotting factors such as factor V.
VIIIa cofactor activity (6) . Cleavage at the former site exposes a functional factor IXainteractive site within the A2 domain that is cryptic in the unactivated molecule (7) .
Cleavage at the latter site liberates the cofactor from its carrier protein, VWF (8) ,
contributing to the overall specific activity of the cofactor (9, 10) .
Factor VIIIa cofactor activity is downregulated in the presence of serine proteases such as APC (5), factor Xa (5), and factor IXa (11) by proteolytic inactivation following cleavage at Arg 336 within the A1 subunit.
This inactivation appears to be the result of altered interaction with the A2 subunit and an increased K m of the truncated A1 for the substrate factor X (12, 13), the latter reaction reflecting loss of a factor X-interactive site within residues 337-372 (14) . Factor Xa and APC also cleave at Lys 36 (13) and at 3 Arg 562 (15) , respectively. These events may alter the conformation of A1, limiting the productive interaction with the A2 subunit (13) and impairing the interaction with factor IXa in tenase complex (16) . Va (17, 18) , IXa (19) , X (20) and factor VIII (21, 22) . These findings suggest that plasmin might down-regulate tenase activity by inactivating factor VIII(a), although the exact mechanism of this inactivation is poorly understood.
In the present study, we report on the mechanism of plasmin-catalyzed factor VIII inactivation. Functional assays and SDS-PAGE analysis using isolated subunits of the cofactor, demonstrated for the first time that inactivation was directly associated with unique, limited-proteolysis that led initially to three terminal products, A1 , A2, and Purified heavy chain was cleaved by thrombin, and the A2 and A1 subunits were purified using Hi-Trap Heparin column and Mono-Q columns, respectively, as reported previously (12) . A3-C1-C2 subunits were purified from thrombin-treated light chain by SP-Sepharose chromatography as previously described (27) . Factor VIIIa was isolated from thrombin-treated factor VIII by CM- (29) .
MATERIALS AND METHODS

Reagents
Clotting assay -Factor VIII(a) activity was measured in a one-stage clotting assay using factor VIII-deficient plasma (30) . All reactions were performed at 22 °C. All factor VIII products were incubated in buffer However, the characteristic "spike" of factor VIIIa activity observed in the presence of plasmin was not observed with factor Xa.
In contrast, a broad activation plateau was seen for approximately 15 min, and was followed by a slower decrease in activity.
The activity of factor VIIIa at any time-point likely represents contributions from unactivated molecules, activated molecules, and activated molecules that have decayed following factor VIII subunit dissociation.
To precisely evaluate the effect of The relationship between these fragments is shown schematically in Figure 3B . (17), and the mechanism has been described to be associated with critical residues 307-348 of the factor V molecule (18) . Similarly, plasmin-induced cleavage and inactivation of factor X appeared to be lipid-dependent (20) . Factor VIII and factor V are structurally homologous (43) , and our data imply distinct similarities in the action of plasmin on factor VIII and factor V.
Factor VIII circulates in a noncovalent A comparison of the proteolysis of the factor VIII heavy chain by plasmin, APC, and factor Xa is schematically illustrated in Figure 7 .
These mechanisms have been well described.
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APC cleaves factor VIII at Arg 336 within the (18) and factor IX (19) has been also reported. Factor VIII (500 nM) was incubated with plasmin (10 nM) in the presence of phospholipid vesicles (10 µM) for the indicated times as described under "Materials and Methods".
Samples were run on 8% gel followed by Western blotting using anti-A1 (58. Data were extrapolated using a single exponential decay curve. 
